FDA Variance Amendment from DePaul University Idea Realization Laboratory

The FDA has made available a variance amendment submitted by DePaul University's Idea Realization Laboratory. This filing, associated with CDRH, indicates a specific request or modification related to regulatory requirements, though the exact nature of the variance is not detailed in the provided metadata. The document is listed under docket number FDA-2026-V-1761-0003.

Compliance officers should note that while this is a variance amendment, the lack of available content and specific details means immediate action is likely not required unless directly involved with DePaul University's Idea Realization Laboratory or related research. Further review of the attached PDF is recommended for a complete understanding of the amendment's scope and implications.